Drugs / Tetanus, Diphtheria, and Pertussis Vaccine
last change May 2018 re-read 2 minutes ago

Tetanus, Diphtheria, and Pertussis Vaccine

Vaccine

Investigated by
Centers for Disease Control and Prevention · Children's Hospital Medical Center, Cincinnati · Duke University

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02783170 Sep 2016 → Apr 2018 pregnancy disorder Duke University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tetanus, Diphtheria, and Pertussis Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02783170
Modality Vaccine “Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap)” NCT02783170
Route Intramuscular “single intramuscular (IM) 0.5 mL dose” NCT02783170